Clinical Trials Logo

Preventable Disease, Vaccine clinical trials

View clinical trials related to Preventable Disease, Vaccine.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05846178 Completed - Clinical trials for Health Knowledge, Attitudes, Practice

Digital Storytelling Intervention to Promote HPV Vaccination in Korean American Youths

Start date: March 24, 2020
Phase: N/A
Study type: Interventional

Asian American (AA) females are disproportionately affected by cervical cancer. Among AA subgroups, Korean American (KA) females had higher risks of developing cervical cancer and rates of cervical cancer mortality compared to white females (11.9, 7.1 per 100,000, respectively). Despite that HPV vaccines have shown to be efficacious in preventing cancers and are recommended for routine vaccinations for youth at age 11 or 12 years, AA females aged 9-17 years have significantly lower HPV vaccine initiation (12.4% vs 27.2%) and completion (1.9% vs 10.3%) rates compared with all other race/ethnicities combined. Using culturally grounded narratives/stories incorporating culture-specific beliefs and practices for health behavior change is effective to mitigate health disparities, specifically for Asian Americans. Storytelling, a specific form of cultural narrative, is showing promise as an effective method of facilitating healthy behaviors through promoting a sense of identification with stories and characters, and transportation (i.e., emotional engagement) as defined in the Model of Narrative as Culture-Centric Health Promotion. We propose to use a digital storytelling approach to gather in-person stories from KA immigrant mothers about HPV vaccination of their children for our intervention.

NCT ID: NCT05178134 Completed - Clinical trials for Preventable Disease, Vaccine

A Phase 2 Bridging Study to Assess the New Formulation of ETVAX

Start date: November 8, 2021
Phase: Phase 2
Study type: Interventional

This is a phase 2,prospective double-blind, randomized, parallel-group study with the aim to demonstrate non-inferiority, in terms of immunogenicity, between the wet formulation and a newly developed partially dried formulation of selected components of ETVAX.

NCT ID: NCT04567342 Completed - Clinical trials for Health Care Utilization

Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of MMR Vaccination

Start date: November 27, 2020
Phase: N/A
Study type: Interventional

Our objective is to determine the effectiveness of varied outreach methods (e.g. automated reminder calls/text messages with or without personalized calls/texts) to children age 12-14 months or 4 years old who are due for a WCC visit and don't have one scheduled in the next 45 days on the outcomes of appointment scheduling, appointment completion, and receipt of the MMR vaccination.